NCT06260800

Brief Summary

Physiotherapy treatment of musculoskeletal injuries should be performed following the main clinical guidelines of person-centered care. Patients' perception of the abilities and facilities provided by physiotherapists boost a convenient therapeutic relationship. This relation is linked with more satisfaction and adherence during the treatment, as well as credibility and expectancy of the patient related to the treatment. Thus, Credibility and Expectancy questionnaire is normally used to assess that point. CEQ presents good psychometric properties when used in Physisiotherapy interventions, but there is not a spanish version of this questionaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

January 8, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2024

Completed
Last Updated

December 31, 2025

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

December 18, 2023

Last Update Submit

December 26, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Content validity

    Credibility and Expectancy questionnaire (CEQ) must be completed, while registering the time used and the quality and the reading comprehension.

    During the intervention: Session 1

  • Structural validity

    Exploratory factor analysis (EFA) and confirmatory factorial analysis (CFA) were performed. For EFA Kaiser criterion \>0.70 will be acceptable. For CFA, goodness of fit index and comparative fit index were calculated, where values up to 0.90 were acceptable.

    During the intervention: session 1 and 2 treatment

  • Reliability

    Credibility and Expectancy questionnaire (CEQ) reliability will be analised through internal consistency (alpha Cronbach \> 0.70 recomended)) and test-retest (intraclass correlation coeficient \>0.70 acceptable).

    During the intervention.

  • Hypotheses testing for construct validity

    Comparing CEQ with other measurement instruments.

    During the intervention.

Study Arms (1)

CEQ Validation

In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session.

Other: Validation CEQ

Interventions

In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session.

CEQ Validation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who are going to start physiotherapy treatment due to musculoskeletal injuries.

You may qualify if:

  • Volunteer patients who are going to start physiotherapy treatment due to musculoskeletal injuries.
  • Age above 18 years old.
  • Understanding of the study purpose and signing the informed consent.

You may not qualify if:

  • Patients with cognitive deprivation.
  • Not able to fill in the questionnaires autonomously.
  • Mother tongue different from Spanish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Silvia Lahuerta Martín

Soria, 42004, Spain

Location

Study Officials

  • Silvia Lahuerta Martín

    University of Valladolid, Soria, Spain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 18, 2023

First Posted

February 15, 2024

Study Start

January 8, 2024

Primary Completion

July 15, 2024

Study Completion

December 4, 2024

Last Updated

December 31, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations